The Calculated Panel Reactive Antibody (CPRA) will be used in the allocation of kidney, pancreas, and kidney-pancreas organs as a measure of sensitization level. The CPRA estimates the percentage of donors that would be incompatible with the candidate, based on the candidate's unacceptable antigens.